Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 622 for “"Multiforme"”.

  1. Glioblastoma multiforme

    … wissenschaftliche Arbeit zum Thema Glioblastoma multiforme. Es werden mit Hilfe szientometrischer Methoden und Werkzeuge die wichtigsten Akteure der wissenschaftlichen Beschäftigung mit diesem Thema analysiert und dargestellt sowie qualitativ bewertet.

    fu-berlin Repository record for Glioblastoma multiforme (opens in a new tab)

  2. Nucleosome repositioning in Glioblastoma Multiforme

    Glioblastoma multiforme (GBM) is an intrusive malignant tumour that accounts for 60% of brain tumours in adults. GBM is aggressive and has a poor prognosis. Astrocytomas are derived from a type of brain cell called astrocyte, a star-shaped cell. Genetic or epigenetic changes in astrocytes cause …

    essex Download PDF for Nucleosome repositioning in Glioblastoma Multiforme (opens in a new tab) Embargoed until 2029-05-02

  3. Bioengineering of Heterogenous Glioblastoma Multiforme Microenvironment

    Glioblastoma (GBM) is the most aggressive brain tumor that originates from glioblastoma stem cells (GSCs). In the brain, GSCs are supported by a tumor microenvironment (TME) wherein the perivascular niche and hypoxic region are present. The glioblastoma microenvironment (GBME) exhibits high …

    alabama Repository record for Bioengineering of Heterogenous Glioblastoma Multiforme Microenvironment (opens in a new tab)

  4. Mechanism of NANOGP8 in Glioblastoma Multiforme

    Glioblastoma multiforme (GBM) is an incurable brain tumor, with patients only expecting to live 15 to 16 months post-diagnosis with the most current treatments options including surgery, chemotherapy, and radiation. How GBM resist treatment is still not very well known. However, cancer stem cells …

    ucf Repository record for Mechanism of NANOGP8 in Glioblastoma Multiforme (opens in a new tab)

  5. GATA4 Represses Formation of Glioblastoma Multiforme

    … adult CNS with significant loss in Glioblastoma Multiforme (GBM). GBM is the most common and lethal primary brain tumour and exhibits multiple molecular aberrations. Here we report that loss of the transcription factor GATA4, a negative regulator of normal astrocyte proliferation, is a driver in …

    toronto-retro Repository record for GATA4 Represses Formation of Glioblastoma Multiforme (opens in a new tab)

  6. Die zielgerichtete Therapie des Glioblastoma multiforme

    Die zielgerichtete Therapie von Tumorerkrankungen erhielt in den letzten Jahren immer mehr Einzug in die moderne Onkologie und zeigte dort bei vielen verschiedenen Tumorentitäten sehr gute Wirkungen. Auch für maligne Gliome stellt die targeted therapy eine neue Behandlungsmöglichkeit dar. In diesen …

    fu-berlin Repository record for Die zielgerichtete Therapie des Glioblastoma multiforme (opens in a new tab)

  7. Glioblastoma multiforme: etiology, progression, and treatment

    Glioblastoma multiforme is the most common and malignant brain tumor, accounting for more than 52% of all primary brain tumors. The molecular heterogeneity of the tumor has made it difficult to treat, and even more difficult to cure. Due to the high mortality rate associated with the current …

    bu Repository record for Glioblastoma multiforme: etiology, progression, and treatment (opens in a new tab)

  8. Examination of Glioblastoma Multiforme during Growth & Treatment

    Glioblastoma multiforme is the most aggressive primary brain tumor in humans, exhibiting a rapid and infiltrative growth pattern and a limited response to treatments, including radiation therapy. Despite considerable advances in glioma research over recent decades, numerous questions remain …

    zurich Restricted access

  9. CHARACTERIZATION OF THERANOSTIC PEPTIDES FOR GLIOBLASTOMA MULTIFORME

    Glioblastoma multiforme (GBM) is a type of primary CNS tumor in which viable treatment options do not exist. Standard of care including tumor resection, chemotherapy, and radiation does little to extend the 5-year survival expectancy past 5.1%. Herein, two small-peptide molecules with inherent …

    nmu Repository record for CHARACTERIZATION OF THERANOSTIC PEPTIDES FOR GLIOBLASTOMA MULTIFORME (opens in a new tab)

  10. Glutamatstoffwechsel in Glioblastoma multiforme WHO-Grad IV

    qucosa-diss

  11. MicroRNA modulation networks in Glioblastoma Multiforme subtypes

    Because Glioblastoma Multiforme (GBM) usually results in death for most patients diagnosed, it is extremely important to delineate the molecular subtypes of GBM and determine molecular targets for therapy. Though there have been various previous studies that have determined subtypes for GBM, there …

    bu Repository record for MicroRNA modulation networks in Glioblastoma Multiforme subtypes (opens in a new tab)

  12. Landscape of nucleosome repositioning in glioblastoma multiforme

    Glioblastoma (GBM) is classified as a grade IV astrocytoma, characterised by its aggressive nature and poor prognosis. It represents a major problem in oncology given its abysmal survival rate and lack of effective treatment options to cure the malignancy and prevent relapses. The current methods …

    essex Download PDF for Landscape of nucleosome repositioning in glioblastoma multiforme (opens in a new tab) Embargoed until 2031-02-26

  13. Neuartige Zielvolumendefinition für die Strahlentherapie des Glioblastoma multiforme

    Background: For target delineation in Glioblastoma there are currently two major consensus guidelines being used, the one of the European Organisation for Research and Treatment of Cancer (EORTC) and the one of the Radiation Therapy Oncology Group (RTOG). The resulting target volumes are often …

    freiburg-diss Repository record for Neuartige Zielvolumendefinition für die Strahlentherapie des Glioblastoma multiforme (opens in a new tab)

  14. MESENCHYMAL STEM CELLS AS THERAPY AGAINST HUMAN GLIOBLASTOMA MULTIFORME

    Prognosis for glioblastoma multiforme (GBM) patients remains dismal despite advancement in surgical techniques and standard therapies. Alternative gene therapy using tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), although used extensively in cancer therapy, is of limited efficacy …

    nus Repository record for MESENCHYMAL STEM CELLS AS THERAPY AGAINST HUMAN GLIOBLASTOMA MULTIFORME (opens in a new tab) Download file for MESENCHYMAL STEM CELLS AS THERAPY AGAINST HUMAN GLIOBLASTOMA MULTIFORME (opens in a new tab)

  15. Investigating resistance of glioblastoma multiforme to radiotherapy and chemotherapy

    <p>Glioblastoma multiforme (GBM) is the most common and aggressive type of brain tumour. Despite treatment with surgery, radiotherapy and temozolomide (TMZ) chemotherapy, patient survival remains poor, suggesting that GBM cells evade and resist these therapies. The insulin-like growth factor 1 …

    oxford Repository record for Investigating resistance of glioblastoma multiforme to radiotherapy and chemotherapy (opens in a new tab)

  16. Peptide Conjugates for MicroRNA-21 Inhibition in Glioblastoma Multiforme

    Glioblastoma multiforme (GBM) is the most common and lethal primary malignant brain tumour in adults (Osuka and Van Meir, 2017), following diagnosis it is estimated that less than 5% of GBM patients survive for more than 5 years (Tamimi and Juweid,2017). The current standard practise for GBM …

    liverpool-jm Repository record for Peptide Conjugates for MicroRNA-21 Inhibition in Glioblastoma Multiforme (opens in a new tab) Download PDF for Peptide Conjugates for MicroRNA-21 Inhibition in Glioblastoma Multiforme (opens in a new tab)

Page 1 of 32